Printer Friendly

Watson Pharmaceuticals Inc anticipates adjusted cash earnings per share to be at or slightly above USD3.37 to USD3.45 for FY 2010.

M2 EQUITYBITES-January 13, 2011-Watson Pharmaceuticals Inc anticipates adjusted cash earnings per share to be at or slightly above USD3.37 to USD3.45 for FY 2010(C)2011 M2 COMMUNICATIONS http://www.m2.com

Specialist pharmaceutical company Watson Pharmaceuticals Inc (NYSE:WPI) said on Wednesday that it expects its adjusted cash earnings per share to be at or slightly above the midpoint of the latest forecast of USD3.37 to USD3.45 for FY 2010.

This new forecast reflects a growth of 12% over 2009.

The company expects net revenues to go up by more than 25% to more than USD3.5bn for FY 2010 as compared to 2009.

According to the company, the new outlook is based on a preliminary review of its operating results for the fourth quarter and year-ended 31 December 2010.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2011 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jan 13, 2011
Words:146
Previous Article:International Flavors & Fragrances Inc proposes over USD100m in investment in Greater Asia.
Next Article:Daiichi Sankyo Company Ltd and ArQule Inc enrol first patient in Phase 3 trial of ARQ 197 for NSCLC.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters